Avalon Pharma Signs MoU with Benta to Advance Innovative and Specialized Pharmaceutical Manufacturing in Saudi Arabia

Avalon Pharma is proud to announce the signing of a Memorandum of Understanding (MoU) with Benta, a global leader in pharmaceutical manufacturing and biotechnologies. The strategic collaboration aims to advance innovative and specialized pharmaceutical products within the Kingdom of Saudi Arabia, in alignment with Saudi Vision 2030 and the National Industrial Strategy.

This partnership reflects Avalon Pharma’s ongoing commitment to promoting the localization of advanced healthcare industries, transferring high-value technologies, and building strategic global alliances that support the Kingdom’s transformation into a regional hub for advanced health manufacturing.

Through this collaboration, Avalon Pharma reaffirms its role in strengthening the national pharmaceutical ecosystem and fostering innovation as a key driver for the future of the healthcare and industrial sectors.

#Avalon_Pharma #Benta #Pharmaceutical_Industry #Biotechnology #Saudi_Vision_2030 #National_Industrial_Strategy